Stat1とStat3による転写の最大活性化には,チロシンとセリンの両方のリン酸化が必要です
1Laboratory of Molecular Cell Biology, Rockefeller University, New York, New York 10021-6399, USA.
Cell
|July 28, 1995
まとめ
シグナルトランスデューサーとトランスクリプション (Stat) タンパク質のアクティベーターは,最大限の遺伝子活性化のためにチロシンとセリンの両方のリン酸化を必要とします. サイトカインと成長因子はこれらのリン酸化現象を誘発し,Statタンパク質の機能におけるセリンキナーゼの役割を強調する.
科学分野:
- 分子生物学は分子生物学である.
- 細胞シグナル伝達 細胞信号伝達
- 遺伝子規制 遺伝子規制
背景:
- シグナルトランスデューサーとトランスクリプション (Stat) タンパク質のアクティベーターは,潜伏トランスクリプション因子である.
- ステートタンパク質の活性化は,サイトカインと成長因子受容体に結合したチロシンリン酸化によって開始されます.
研究 の 目的:
- Stat1およびStat3の転写活動におけるセリンリン酸化の役割を調査する.
- Statタンパク質による最大遺伝子活性化のためにセリンリン酸化が必要かどうかを判断する.
主な方法:
- 研究されたStat1とStat3のリン酸化.
- サイトカインと成長因子刺激を用いた.
- リン酸化イベントに反応する転写活性を評価した.
主要な成果:
- Stat1とStat3は,最大限の転写活性のために,特定のセリン残留物 (Ser727) のリン酸化を必要とします.
- サイトカインと成長因子の両方が,Stat1とStat3のセリンリン酸化を誘導する.
- Statタンパク質による最大遺伝子活性化は,チロシンリン酸化とセリンキナーゼの両方に依存する.
結論:
- セリンリン酸化は,Stat1およびStat3機能の重要な規制ステップです.
- この発見は,Stat媒介遺伝子発現に不可欠な二重リン酸化機構 (タイロシンとセリン) を明らかにしています.
- これは,サイトカインと成長因子シグナル伝達経路におけるセリンキナーゼの重要性を強調しています.
さらに関連する動画
関連する概念動画
02:36RNA Polymerase II Accessory Proteins
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
02:42Eukaryotic Transcription Activators
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...